{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:56:17Z","timestamp":1793044577074,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK119066"],"award-info":[{"award-number":["DK119066"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Saunders Endowment"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s11010-023-04865-2","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T09:02:49Z","timestamp":1696323769000},"page":"2429-2445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Development and testing of nanoparticles delivery for P7C3 small molecule using injury models"],"prefix":"10.1007","volume":"479","author":[{"given":"Vijaykumar","family":"Sutariya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aren","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraian","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin L.","family":"Badole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Tur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie","family":"Gittinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joung Woul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravikumar","family":"Manickam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas M.","family":"Tipparaju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,3]]},"reference":[{"key":"4865_CR1","doi-asserted-by":"publisher","unstructured":"Najahi-Missaoui W, Arnold RD, Cummings BS (2020) Safe nanoparticles: are we there yet? Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/ijms22010385","DOI":"10.3390\/ijms22010385"},{"key":"4865_CR2","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1007\/s11010-022-04408-1","volume":"477","author":"S Wagner","year":"2022","unstructured":"Wagner S, Manickam R, Brotto M, Tipparaju SM (2022) NAD(+) centric mechanisms and molecular determinants of skeletal muscle disease and aging. Mol Cell Biochem 477:1829\u20131848. https:\/\/doi.org\/10.1007\/s11010-022-04408-1","journal-title":"Mol Cell Biochem"},{"key":"4865_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.06.018","volume":"142","author":"AA Pieper","year":"2010","unstructured":"Pieper AA, Xie S, Capota E, Estill SJ, Zhong J, Long JM, Becker GL, Huntington P, Goldman SE, Shen CH, Capota M, Britt JK, Kotti T, Ure K, Brat DJ, Williams NS, MacMillan KS, Naidoo J, Melito L, Hsieh J, De Brabander J, Ready JM, McKnight SL (2010) Discovery of a proneurogenic, neuroprotective chemical. Cell 142:39\u201351. https:\/\/doi.org\/10.1016\/j.cell.2010.06.018","journal-title":"Cell"},{"key":"4865_CR4","doi-asserted-by":"publisher","first-page":"6716","DOI":"10.1039\/C3CS60448A","volume":"43","author":"AA Pieper","year":"2014","unstructured":"Pieper AA, McKnight SL, Ready JM (2014) P7C3 and an unbiased approach to drug discovery for neurodegenerative diseases. Chem Soc Rev 43:6716\u20136726. https:\/\/doi.org\/10.1039\/C3CS60448A","journal-title":"Chem Soc Rev"},{"key":"4865_CR5","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1167\/iovs.17-22179","volume":"58","author":"H Oku","year":"2017","unstructured":"Oku H, Morishita S, Horie T, Kida T, Mimura M, Kojima S, Ikeda T (2017) P7C3 suppresses neuroinflammation and protects retinal ganglion cells of rats from Optic nerve crush. Invest Ophthalmol Vis Sci 58:4877\u20134888. https:\/\/doi.org\/10.1167\/iovs.17-22179","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4865_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.cmet.2018.02.011","volume":"27","author":"L Rajman","year":"2018","unstructured":"Rajman L, Chwalek K, Sinclair DA (2018) Therapeutic potential of NAD-Boosting molecules: the in vivo evidence. Cell Metab 27:529\u2013547. https:\/\/doi.org\/10.1016\/j.cmet.2018.02.011","journal-title":"Cell Metab"},{"key":"4865_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12887","author":"R Manickam","year":"2022","unstructured":"Manickam R, Tur J, Badole SL, Chapalamadugu KC, Sinha P, Wang Z, Russ DW, Brotto M, Tipparaju SM (2022) Nampt activator P7C3 ameliorates diabetes and improves skeletal muscle function modulating cell metabolism and lipid mediators. J Cachexia Sarcopenia Muscle. https:\/\/doi.org\/10.1002\/jcsm.12887","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4865_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.yjmcc.2019.09.013","volume":"137","author":"PJ Kilfoil","year":"2019","unstructured":"Kilfoil PJ, Chapalamadugu KC, Hu X, Zhang D, Raucci FJ Jr., Tur J, Brittian KR, Jones SP, Bhatnagar A, Tipparaju SM, Nystoriak MA (2019) Metabolic regulation of Kv channels and cardiac repolarization by Kv\u03b22 subunits. J Mol Cell Cardiol 137:93\u2013106. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.09.013","journal-title":"J Mol Cell Cardiol"},{"key":"4865_CR9","doi-asserted-by":"publisher","first-page":"H571","DOI":"10.1152\/ajpheart.00281.2016","volume":"312","author":"J Tur","year":"2017","unstructured":"Tur J, Chapalamadugu KC, Katnik C, Cuevas J, Bhatnagar A, Tipparaju SM (2017) Kv\u03b21.1 (AKR6A8) senses pyridine nucleotide changes in the mouse heart and modulates cardiac electrical activity. Am J Physiol Heart Circ Physiol 312:H571\u2013h583. https:\/\/doi.org\/10.1152\/ajpheart.00281.2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4865_CR10","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1080\/10717544.2021.1938756","volume":"28","author":"Y Su","year":"2021","unstructured":"Su Y, Zhang B, Sun R, Liu W, Zhu Q, Zhang X, Wang R, Chen C (2021) PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application. Drug Deliv 28:1397\u20131418. https:\/\/doi.org\/10.1080\/10717544.2021.1938756","journal-title":"Drug Deliv"},{"key":"4865_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0142-9612(96)85754-1","volume":"17","author":"KA Athanasiou","year":"1996","unstructured":"Athanasiou KA, Niederauer GG, Agrawal CM (1996) Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid\/ polyglycolic acid copolymers. Biomaterials 17:93\u2013102. https:\/\/doi.org\/10.1016\/0142-9612(96)85754-1","journal-title":"Biomaterials"},{"key":"4865_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1208\/s12249-019-1474-0","volume":"20","author":"P Bhatt","year":"2019","unstructured":"Bhatt P, Narvekar P, Lalani R, Chougule MB, Pathak Y, Sutariya V (2019) An in vitro Assessment of Thermo-Reversible gel Formulation Containing Sunitinib Nanoparticles for Neovascular Age-Related Macular Degeneration. AAPS PharmSciTech 20:281. https:\/\/doi.org\/10.1208\/s12249-019-1474-0","journal-title":"AAPS PharmSciTech"},{"key":"4865_CR13","doi-asserted-by":"publisher","first-page":"1000164","DOI":"10.4172\/2157-7439.1000164","volume":"4","author":"P Ma","year":"2013","unstructured":"Ma P, Mumper RJ (2013) Paclitaxel Nano-Delivery Systems: a Comprehensive Review. J Nanomed Nanatechnol 4:1000164\u20131000164. https:\/\/doi.org\/10.4172\/2157-7439.1000164","journal-title":"J Nanomed Nanatechnol"},{"key":"4865_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.addr.2010.10.008","volume":"63","author":"S Acharya","year":"2011","unstructured":"Acharya S, Sahoo SK (2011) PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev 63:170\u2013183. https:\/\/doi.org\/10.1016\/j.addr.2010.10.008","journal-title":"Adv Drug Deliv Rev"},{"key":"4865_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nnano.2010.246","volume":"6","author":"T Dvir","year":"2011","unstructured":"Dvir T, Timko BP, Kohane DS, Langer R (2011) Nanotechnological strategies for engineering complex tissues. Nat Nanotechnol 6:13\u201322. https:\/\/doi.org\/10.1038\/nnano.2010.246","journal-title":"Nat Nanotechnol"},{"key":"4865_CR16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1080\/02652048.2018.1453560","volume":"35","author":"J Patel","year":"2018","unstructured":"Patel J, Amrutiya J, Bhatt P, Javia A, Jain M, Misra A (2018) Targeted delivery of monoclonal antibody conjugated docetaxel loaded PLGA nanoparticles into EGFR overexpressed lung tumour cells. J Microencapsul 35:204\u2013217. https:\/\/doi.org\/10.1080\/02652048.2018.1453560","journal-title":"J Microencapsul"},{"key":"4865_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1146\/annurev-pharmtox-010716-104558","volume":"57","author":"SM Nimjee","year":"2017","unstructured":"Nimjee SM, White RR, Becker RC, Sullenger BA (2017) Aptamers as therapeutics. Annu Rev Pharmacol Toxicol 57:61\u201379. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010716-104558","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"4865_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11010-007-9555-x","volume":"306","author":"Y Hui","year":"2007","unstructured":"Hui Y, Shan L, Lin-Fu Z, Jian-Hua Z (2007) Selection of DNA aptamers against DC-SIGN protein. Mol Cell Biochem 306:71\u201377. https:\/\/doi.org\/10.1007\/s11010-007-9555-x","journal-title":"Mol Cell Biochem"},{"key":"4865_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.1063273","volume":"293","author":"R Langer","year":"2001","unstructured":"Langer R (2001) Drugs on target. Science 293:58\u201359. https:\/\/doi.org\/10.1126\/science.1063273","journal-title":"Science"},{"key":"4865_CR20","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.addr.2004.02.014","volume":"56","author":"L Brannon-Peppas","year":"2004","unstructured":"Brannon-Peppas L, Blanchette JO (2004) Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 56:1649\u20131659. https:\/\/doi.org\/10.1016\/j.addr.2004.02.014","journal-title":"Adv Drug Deliv Rev"},{"key":"4865_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.omtn.2017.12.004","volume":"10","author":"S Philippou","year":"2018","unstructured":"Philippou S, Mastroyiannopoulos NP, Makrides N, Lederer CW, Kleanthous M, Phylactou LA (2018) Selection and identification of skeletal-muscle-targeted RNA aptamers. Mol Therapy - Nucleic Acids 10:199\u2013214. https:\/\/doi.org\/10.1016\/j.omtn.2017.12.004","journal-title":"Mol Therapy - Nucleic Acids"},{"key":"4865_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/adt.2019.920","volume":"17","author":"P Narvekar","year":"2019","unstructured":"Narvekar P, Bhatt P, Fnu G, Sutariya V (2019) Axitinib-Loaded poly(Lactic-Co-Glycolic acid) nanoparticles for age-related Macular Degeneration: Formulation Development and in Vitro characterization. Assay Drug Dev Technol 17:167\u2013177. https:\/\/doi.org\/10.1089\/adt.2019.920","journal-title":"Assay Drug Dev Technol"},{"key":"4865_CR23","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1139\/cjpp-2018-0569","volume":"97","author":"V Sutariya","year":"2019","unstructured":"Sutariya V, Kelly SJ, Weigel RG, Tur J, Halasz K, Sharma NS, Tipparaju SM (2019) Nanoparticle drug delivery characterization for fluticasone propionate and in vitro testing (1). Can J Physiol Pharmacol 97:675\u2013684. https:\/\/doi.org\/10.1139\/cjpp-2018-0569","journal-title":"Can J Physiol Pharmacol"},{"key":"4865_CR24","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/J.JDDST.2018.03.027","volume":"45","author":"C Yewale","year":"2018","unstructured":"Yewale C, Baradia D, Patil S, Bhatt P, Amrutiya J, Gandhi R, Kore G, Misra A (2018) Docetaxel loaded immunonanoparticles delivery in EGFR overexpressed breast carcinoma cells. J Drug Deliv Sci Technol 45:334\u2013345. https:\/\/doi.org\/10.1016\/J.JDDST.2018.03.027","journal-title":"J Drug Deliv Sci Technol"},{"key":"4865_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijpharm.2017.11.048","volume":"536","author":"P Bhatt","year":"2018","unstructured":"Bhatt P, Lalani R, Vhora I, Patil S, Amrutiya J, Misra A, Mashru R (2018) Liposomes encapsulating native and cyclodextrin enclosed paclitaxel: enhanced loading efficiency and its pharmacokinetic evaluation. Int J Pharm 536:95\u2013107. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.11.048","journal-title":"Int J Pharm"},{"key":"4865_CR26","doi-asserted-by":"publisher","unstructured":"Bhatt P, Narvekar P, Lalani R, Chougule MB, Pathak Y, Sutariya V (2019) An in vitro Assessment of Thermo-Reversible gel Formulation Containing Sunitinib Nanoparticles for Neovascular Age-Related Macular Degeneration. AAPS PharmSciTech 20. https:\/\/doi.org\/10.1208\/s12249-019-1474-0","DOI":"10.1208\/s12249-019-1474-0"},{"key":"4865_CR27","doi-asserted-by":"publisher","first-page":"e87326","DOI":"10.1371\/journal.pone.0087326","volume":"9","author":"DL Cooper","year":"2014","unstructured":"Cooper DL, Harirforoosh S (2014) Design and optimization of PLGA-based diclofenac loaded nanoparticles. PLoS ONE 9:e87326. https:\/\/doi.org\/10.1371\/journal.pone.0087326","journal-title":"PLoS ONE"},{"key":"4865_CR28","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1139\/cjpp-2017-0795","volume":"96","author":"V Sutariya","year":"2018","unstructured":"Sutariya V, Tur J, Kelly S, Halasz K, Chapalamadugu KC, Nimbalkar R, Pathak YV, Weigel R, Daviau T, Webb T, Cacace J, Brotto M, Tipparaju SM (2018) Nanodrug delivery platform for glucocorticoid use in skeletal muscle injury. Can J Physiol Pharmacol 96:681\u2013689. https:\/\/doi.org\/10.1139\/cjpp-2017-0795","journal-title":"Can J Physiol Pharmacol"},{"key":"4865_CR29","doi-asserted-by":"publisher","unstructured":"Khanal S, Adhikari U, Rijal NP, Bhattarai SR, Sankar J, Bhattarai N (2016) pH-Responsive PLGA nanoparticle for controlled payload delivery of Diclofenac Sodium. J Funct Biomater 7. https:\/\/doi.org\/10.3390\/jfb7030021","DOI":"10.3390\/jfb7030021"},{"key":"4865_CR30","unstructured":"Tur JB, Manickam SL, Chapalamadugu R, Xuan KC, Guida W, Crews W, Bisht JJ, Tipparaju KS SM (2022) Cardioprotective effects of P7C3 in diabetic hearts via Nampt activation. Journal of Pharmacology and Experimental Therapeutics"},{"key":"4865_CR31","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/jbm.b.34208","volume":"107","author":"MB Sokol","year":"2019","unstructured":"Sokol MB, Nikolskaya ED, Yabbarov NG, Zenin VA, Faustova MR, Belov AV, Zhunina OA, Mollaev MD, Zabolotsky AI, Tereshchenko OG, Severin ES (2019) Development of novel PLGA nanoparticles with co-encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells. J Biomed Mater Res B Appl Biomater 107:1150\u20131158. https:\/\/doi.org\/10.1002\/jbm.b.34208","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"4865_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3109\/02652048.2015.1115901","volume":"33","author":"D Alt\u0131ndal","year":"2016","unstructured":"Alt\u0131ndal D, G\u00fcm\u00fc\u015fderelio\u011flu M (2016) Melatonin releasing PLGA micro\/nanoparticles and their effect on osteosarcoma cells. J Microencapsul 33:53\u201363. https:\/\/doi.org\/10.3109\/02652048.2015.1115901","journal-title":"J Microencapsul"},{"key":"4865_CR33","doi-asserted-by":"publisher","first-page":"052601","DOI":"10.1063\/1.4916230","volume":"9","author":"MN Hsu","year":"2015","unstructured":"Hsu MN, Luo R, Kwek KZ, Por YC, Zhang Y, Chen CH (2015) Sustained release of hydrophobic drugs by the microfluidic assembly of multistage microgel\/poly (lactic-co-glycolic acid) nanoparticle composites. Biomicrofluidics 9:052601. https:\/\/doi.org\/10.1063\/1.4916230","journal-title":"Biomicrofluidics"},{"key":"4865_CR34","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1002\/jps.21158","volume":"97","author":"DK Sahana","year":"2008","unstructured":"Sahana DK, Mittal G, Bhardwaj V, Kumar MN (2008) PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug. J Pharm Sci 97:1530\u20131542. https:\/\/doi.org\/10.1002\/jps.21158","journal-title":"J Pharm Sci"},{"key":"4865_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-022-04408-1","author":"S Wagner","year":"2022","unstructured":"Wagner S, Manickam R, Brotto M, Tipparaju SM (2022) NAD(+) centric mechanisms and molecular determinants of skeletal muscle disease and aging. Mol Cell Biochem doi. https:\/\/doi.org\/10.1007\/s11010-022-04408-1","journal-title":"Mol Cell Biochem doi"},{"key":"4865_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1021\/nn900002m","volume":"3","author":"OC Farokhzad","year":"2009","unstructured":"Farokhzad OC, Langer R (2009) Impact of Nanotechnology on Drug Delivery. ACS Nano 3:16\u201320. https:\/\/doi.org\/10.1021\/nn900002m","journal-title":"ACS Nano"},{"key":"4865_CR37","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.tibtech.2008.04.006","volume":"26","author":"E Levy-Nissenbaum","year":"2008","unstructured":"Levy-Nissenbaum E, Radovic-Moreno AF, Wang AZ, Langer R, Farokhzad OC (2008) Nanotechnology and aptamers: applications in drug delivery. Trends Biotechnol 26:442\u2013449. https:\/\/doi.org\/10.1016\/j.tibtech.2008.04.006","journal-title":"Trends Biotechnol"},{"key":"4865_CR38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.neuropharm.2018.09.024","volume":"145","author":"MO Blaya","year":"2019","unstructured":"Blaya MO, Wasserman JM, Pieper AA, Sick TJ, Bramlett HM, Dietrich WD (2019) Neurotherapeutic capacity of P7C3 agents for the treatment of traumatic brain Injury. Neuropharmacology 145:268\u2013282. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.09.024","journal-title":"Neuropharmacology"},{"key":"4865_CR39","doi-asserted-by":"publisher","unstructured":"Ambasta RK, Sharma A, Kumar P (2011) Nanoparticle mediated targeting of VEGFR and cancer stem cells for cancer therapy. Vascular Cell:26%V 3. https:\/\/doi.org\/10.1186\/2045-824x-3-26","DOI":"10.1186\/2045-824x-3-26"},{"key":"4865_CR40","doi-asserted-by":"publisher","first-page":"e44933","DOI":"10.1371\/journal.pone.0044933","volume":"7","author":"L-Y Liu","year":"2012","unstructured":"Liu L-Y, Wang F, Zhang X-Y, Huang P, Lu Y-B, Wei E-Q, Zhang W-P (2012) Nicotinamide Phosphoribosyltransferase May be involved in age-related Brain Diseases. PLoS ONE 7:e44933. https:\/\/doi.org\/10.1371\/journal.pone.0044933","journal-title":"PLoS ONE"},{"key":"4865_CR41","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/cvr\/cvu220","volume":"104","author":"P Wang","year":"2014","unstructured":"Wang P, Du H, Zhou C-C, Song J, Liu X, Cao X, Mehta JL, Shi Y, Su D-F, Miao C-Y (2014) Intracellular NAMPT\u2013NAD+\u2013SIRT1 cascade improves post-ischaemic vascular repair by modulating notch signalling in endothelial progenitors. Cardiovascular Res 104:477\u2013488. https:\/\/doi.org\/10.1093\/cvr\/cvu220","journal-title":"Cardiovascular Res"},{"key":"4865_CR42","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.intimp.2009.07.001","volume":"9","author":"AR Baudy","year":"2009","unstructured":"Baudy AR, Saxena N, Gordish H, Hoffman EP, Nagaraju K (2009) A robust in vitro screening assay to identify NF-kappaB inhibitors for inflammatory muscle diseases. Int Immunopharmacol 9:1209\u20131214. https:\/\/doi.org\/10.1016\/j.intimp.2009.07.001","journal-title":"Int Immunopharmacol"},{"key":"4865_CR43","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/pmrj.12042","volume":"11","author":"A Stout","year":"2019","unstructured":"Stout A, Friedly J, Standaert CJ (2019) Systemic absorption and side Effects of locally injected glucocorticoids. Pm r 11:409\u2013419. https:\/\/doi.org\/10.1002\/pmrj.12042","journal-title":"Pm r"},{"key":"4865_CR44","volume-title":"Methods and uses of nampt activators for treatment of diabetes, cardiovascular diseases, and symptoms thereof","author":"SM Tipparaju","year":"2020","unstructured":"Tipparaju SM, Badole SL, Chapalamadagu KC, Tur J (2020) Methods and uses of nampt activators for treatment of diabetes, cardiovascular diseases, and symptoms thereof. University of South Florida, USA. https:\/\/uspto.report\/patent\/app\/20200289466"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04865-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-023-04865-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04865-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T19:06:38Z","timestamp":1725390398000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-023-04865-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["4865"],"URL":"https:\/\/doi.org\/10.1007\/s11010-023-04865-2","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,3]]},"assertion":[{"value":"6 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"US Patent: Patent No.: US 11,007,178 B2 []. USF ref. 22A105, 19A039,\u00a024T028. USF Disclosure for aptamer P7C3.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patents"}}]}}